Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Christoph Wanner"'
Autor:
Abhinav Sharma, Silvio E. Inzucchi, Jeffrey M. Testani, Anne Pernille Ofstad, David Fitchett, Michaela Mattheus, Subodh Verma, Faiez Zannad, Christoph Wanner, Bettina J. Kraus
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 737-747 (2024)
Abstract Aims This study aimed to evaluate the bidirectional relationship between kidney and cardiovascular (CV) events in trial participants with type 2 diabetes and CV disease. Methods and results Post hoc analyses of EMPA‐REG OUTCOME using Cox r
Externí odkaz:
https://doaj.org/article/d6eba344c35f43a9afd5fa5b83bba977
Autor:
Piero Ruggenenti, Bettina J. Kraus, Silvio E. Inzucchi, Bernard Zinman, Stefan Hantel, Michaela Mattheus, Maximilian von Eynatten, Giuseppe Remuzzi, Audrey Koitka-Weber, Christoph Wanner
Publikováno v:
EClinicalMedicine, Vol 43, Iss , Pp 101240- (2022)
Summary: Background: Diabetic kidney disease with nephrotic-range proteinuria (NRP) is commonly associated with rapid kidney function loss, increased cardiovascular risk, and premature mortality. We explored the effect of empagliflozin in patients wi
Externí odkaz:
https://doaj.org/article/fbb8fa2282594204a573a3a18cd51d49
Autor:
Nihar R. Desai, Sankar D. Navaneethan, Susanne B. Nicholas, Kevin M. Pantalone, Christoph Wanner, Stefanie Hamacher, Alain Gay, David C. Wheeler
Publikováno v:
Journal of diabetes and its complications, vol 37, iss 4
AimsContemporary patterns of care of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and the adoption of finerenone are not known. The FINE-REAL study (NCT05348733) is a prospective observational study in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74885b81e84665d7ee8df6fb45245a0c
https://escholarship.org/uc/item/5fb525vw
https://escholarship.org/uc/item/5fb525vw
Autor:
Edouard L Fu, Marie Evans, Karin Windahl, Paul Roderick, Christoph Wanner, Friedo W. Dekker, Maciej Szymczak, Claudia Torino, Fergus Caskey, Equal study investigators, Tora Almquist, Nicholas C. Chesnaye, Christiane Drechsler, Kitty J Jager, Gaetana Porto, Gerd Faxén Irving, Maarit Korkeila Lidén, Magdalena Krajewska, Peter Stenvinkel
Publikováno v:
Caskey, F J 2021, ' Patient-reported measures and lifestyle are associated with deterioration in nutritional status in CKD stage 4-5 : the EQUAL cohort study ', Journal of Renal Nutrition . https://doi.org/10.1053/j.jrn.2021.03.006
Journal of renal nutrition, 32(2), 161-169. W.B. Saunders Ltd
Journal of Renal Nutrition, 32(2), 161-169. W B SAUNDERS CO-ELSEVIER INC
Journal of renal nutrition, 32(2), 161-169. W.B. Saunders Ltd
Journal of Renal Nutrition, 32(2), 161-169. W B SAUNDERS CO-ELSEVIER INC
Objective: The aim of this study was to explore the changes in nutritional status before dialysis initiation and to identify modifiable risk factors of nutritional status decline in older adults with advanced renal disease.& nbsp;Design and Methods:
Autor:
Jack F.M. Wetzels, Marian Goicoechea, Mark Woodward, Jürgen Floege, Ronald D. Perrone, Hiddo Heerspink, Francesco Locatelli, Brendon L. Neuen, Di Xie, Philip Kam-Tao Li, Tom Greene, Bart Maes, Annalisa Perna, Christoph Wanner, Tazeen H. Jafar, Enyu Imai, Edward F. Vonesh, Shiyuan Miao, Juhi Chaudhari, Julia B. Lewis, Lesley A. Inker, Hocine Tighiouart, William G. Herrington, Francesco Paolo Schena, Manuel Praga, Fernando C. Fervenza, Tak Mao Chan
Publikováno v:
Journal of the American Society of Nephrology, 33, 2, pp. 291-303
Journal of the American Society of Nephrology, 33, 291-303
J Am Soc Nephrol
Journal of the American Society of Nephrology, 33(2), 291-303. AMER SOC NEPHROLOGY
Journal of the American Society of Nephrology, 33, 291-303
J Am Soc Nephrol
Journal of the American Society of Nephrology, 33(2), 291-303. AMER SOC NEPHROLOGY
Background: Acute changes in glomerular filtration rate (GFR) can occur following initiation of interventions for chronic kidney disease (CKD) progression. These complicate the interpretation of treatment effects on long term progression of (CKD). We
Autor:
Ziad A. Massy, Dimitrios S. Goumenos, Annette Bruchfeld, Ivan Rychlik, Carsten A. Wagner, Hans-Joachim Anders, Tom Oostrom, Carmine Zoccali, Giovambattista Capasso, Ron T. Gansevoort, María José Soler, Kate Stevens, Denis Fouque, Peter J. Blankestijn, Goce Spasovski, Danilo Fliser, Friedo W. Dekker, Kitty J Jager, Mario Cozzolino, Christoph Wanner, Raymond Vanholder
Publikováno v:
Nephrology Dialysis Transplantation, 37(1), 21-28. OXFORD UNIV PRESS
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, pp.gfaa163. ⟨10.1093/ndt/gfaa163⟩
Nephrology Dialysis Transplantation, Oxford University Press, 2020, pp.gfaa163. ⟨10.1093/ndt/gfaa163⟩
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, pp.gfaa163. ⟨10.1093/ndt/gfaa163⟩
Nephrology Dialysis Transplantation, Oxford University Press, 2020, pp.gfaa163. ⟨10.1093/ndt/gfaa163⟩
Medical societies have a social responsibility to disseminate knowledge and inform health authorities on threats to public health posed by various diseases. Advocacy for health protection programmes and for medical research funding is now embedded in
Autor:
Christoph Wanner, Gregorio T. Obrador, Sushrut S. Waikar, Kevin Carroll, Iain C. Macdougall, Rich Davies, Borut Cizman, Scott D. Solomon, David C. Wheeler, Alexander R. Cobitz, Andrzej Wiecek, Vivekanand Jha, Kirsten L. Johansen, Lata Kler, Allison Blackorby, Vlado Perkovic, Ajay K. Singh, Renato D. Lopes, John J.V. McMurray, Amy Meadowcroft
Publikováno v:
Nephrology Dialysis Transplantation. 37:960-972
Background The Anemia Studies in chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor Daprodustat-Dialysis (ASCEND-D) trial will test the hypothesis that daprodustat is noninferior to comparator epoetin alfa or darbep
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 146:317-322
Kidney patients age faster and vascular risk factors intensify the process. Lifetime is reduced up to 16 years in patients with diabetes mellitus type 2 and kidney disease. SGLT2 inhibitors play a significant role in maintaining organ function. By in
Autor:
Fergus Caskey, Christoph Wanner, Paul Roderick, Simon D.S. Fraser, Samantha Hayward, James E. Morris, Maurizio Postorino, Marie Evans, Barnaby Hole, Polly Duncan, Christiane Drechsler, Maciej Szymczak, Nicholas C. Chesnaye, Rupert Payne, Friedo W. Dekker, Kitty J. Jager, Rachel Denholm, Gaetana Porto
Publikováno v:
Nephrology, dialysis, transplantation, 36(3), 503-511. Oxford University Press
Hayward, S, Hole, B, Denholm, R, Duncan, P, Caskey, F J & al., E 2020, ' International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease : results from the European Quality Study ', Nephrology Dialysis Transplantation . https://doi.org/10.1093/ndt/gfaa064
Nephrology Dialysis Transplantation, 36(3), 503-511. OXFORD UNIV PRESS
Hayward, S, Hole, B, Denholm, R, Duncan, P, Caskey, F J & al., E 2020, ' International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease : results from the European Quality Study ', Nephrology Dialysis Transplantation . https://doi.org/10.1093/ndt/gfaa064
Nephrology Dialysis Transplantation, 36(3), 503-511. OXFORD UNIV PRESS
Background People with chronic kidney disease (CKD) are at high risk of polypharmacy. However, no previous study has investigated international prescribing patterns in this group. This article aims to examine prescribing and polypharmacy patterns amo
Autor:
Reinhold Kreutz, Charles J. Ferro, Francesca Mallamaci, Alberto Ortiz, Giuseppe Mancia, Christoph Wanner, Pantelis Sarafidis, Jean-Michel Halimi
Publikováno v:
Journal of Hypertension. 39:1090-1097
Chronic kidney disease (CKD) is a major issue of public health. Hypertension control and use of renin--angiotensin system (RAS) blockers are the cornerstones of treatment for CKD of any cause. However, even under optimal RAS blockade, many individual